Literature DB >> 15728306

The epsilon-sarcoglycan gene in myoclonic syndromes.

E M Valente1, M J Edwards, P Mir, A DiGiorgio, S Salvi, M Davis, N Russo, M Bozi, H-T Kim, G Pennisi, N Quinn, B Dallapiccola, K P Bhatia.   

Abstract

Mutations in the epsilon-sarcoglycan gene (SGCE) are associated with familial myoclonus dystonia, but the full spectrum of the phenotype may not be fully defined. We screened 58 individuals with a range of myoclonic/dystonic syndromes for SGCE mutations. We found mutations (three of them novel) in six (21%) of the 29 patients with essential myoclonus and myoclonic dystonia, but did not find mutations in the 29 patients with other phenotypes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728306     DOI: 10.1212/01.WNL.0000151979.68010.9B

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

Review 1.  Essential pitfalls in "essential" tremor.

Authors:  Alberto J Espay; Anthony E Lang; Roberto Erro; Aristide Merola; Alfonso Fasano; Alfredo Berardelli; Kailash P Bhatia
Journal:  Mov Disord       Date:  2017-01-24       Impact factor: 10.338

2.  Myoclonus-dystonia and Silver-Russell syndrome resulting from maternal uniparental disomy of chromosome 7.

Authors:  M B Sheridan; A Bytyci Telegrafi; V Stinnett; C C Umeh; Z Mari; T M Dawson; J Bodurtha; D A S Batista
Journal:  Clin Genet       Date:  2013-01-20       Impact factor: 4.438

3.  Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes.

Authors:  S Tezenas du Montcel; F Clot; M Vidailhet; E Roze; P Damier; C P Jedynak; A Camuzat; A Lagueny; L Vercueil; D Doummar; L Guyant-Maréchal; J-L Houeto; G Ponsot; S Thobois; M-A Cournelle; A Durr; F Durif; B Echenne; D Hannequin; C Tranchant; A Brice
Journal:  J Med Genet       Date:  2005-10-14       Impact factor: 6.318

4.  Myoclonus-dystonia and epilepsy in a family with a novel epsilon-sarcoglycan mutation.

Authors:  Kristoffer Haugarvoll; Charalampos Tzoulis; Gia T Tran; Bjørn Karlsen; Bernt A Engelsen; Per M Knappskog; Laurence A Bindoff
Journal:  J Neurol       Date:  2013-12-03       Impact factor: 4.849

5.  Metabolic changes in DYT11 myoclonus-dystonia.

Authors:  Maren Carbon; Deborah Raymond; Laurie Ozelius; Rachel Saunders-Pullman; Steven Frucht; Vijay Dhawan; Susan Bressman; David Eidelberg
Journal:  Neurology       Date:  2013-01-02       Impact factor: 9.910

6.  A Novel SGCE Nonsense Variant Associated With Marked Intrafamilial Variability in a Turkish Family With Myoclonus-Dystonia.

Authors:  Murat Gultekin; Neha Prakash; Christos Ganos; Meral Mirza; Ruslan Bayramov; Kailash P Bhatia; Niccolò E Mencacci
Journal:  Mov Disord Clin Pract       Date:  2019-07-17

Review 7.  Update on pediatric dystonias: etiology, epidemiology, and management.

Authors:  Emilio Fernández-Alvarez; Nardo Nardocci
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-04-11

8.  Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome.

Authors:  Jianfeng Xiao; Satya R Vemula; Yi Xue; Mohammad M Khan; Francesca A Carlisle; Adrian J Waite; Derek J Blake; Ioannis Dragatsis; Yu Zhao; Mark S LeDoux
Journal:  Neurobiol Dis       Date:  2016-11-24       Impact factor: 5.996

9.  Tremulous cervical dystonia is likely to be familial: clinical characteristics of a large cohort.

Authors:  I Rubio-Agusti; I Pareés; M Kojovic; M Stamelou; T A Saifee; G Charlesworth; U M Sheerin; M J Edwards; K P Bhatia
Journal:  Parkinsonism Relat Disord       Date:  2013-03-21       Impact factor: 4.891

10.  SGCE mutations cause psychiatric disorders: clinical and genetic characterization.

Authors:  Kathryn J Peall; Daniel J Smith; Manju A Kurian; Mark Wardle; Adrian J Waite; Tammy Hedderly; Jean-Pierre Lin; Martin Smith; Alan Whone; Hardev Pall; Cathy White; Andrew Lux; Philip Jardine; Narinder Bajaj; Bryan Lynch; George Kirov; Sean O'Riordan; Michael Samuel; Timothy Lynch; Mary D King; Patrick F Chinnery; Thomas T Warner; Derek J Blake; Michael J Owen; Huw R Morris
Journal:  Brain       Date:  2013-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.